New technology will allow for the development of innovative drug candidates targeting immune checkpoints NEW YORK, Dec. 28, 2015 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ:IMNP) (“Immune”) a clinical-stage company developing ...